Gene therapy for cerebrovascular disease

Neurosurgery

Volumn 44, Issue 2, 1999, Pages 239-253

  Weihl, Chris ^a   Macdonald, R Loch ^a   Stoodley, Marcus ^a   Lüders, Jürgen ^a   Lin, George ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Cerebrovascular disease; Gene therapy; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

LIPOSOME; NITRIC OXIDE; PLASMID DNA; VIRUS VECTOR;

ADENOVIRUS; ADVENTITIA; CEREBROVASCULAR DISEASE; ENDOTHELIUM; GENE EXPRESSION SYSTEM; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; NEUROSURGERY; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; SUBARACHNOID HEMORRHAGE;

ANIMALS; CEREBROVASCULAR DISORDERS; FEASIBILITY STUDIES; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENETIC VECTORS; HUMANS; PROMOTER REGIONS (GENETICS); TRANSGENES;

EID: 0032938594     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199902000-00001     Document Type: Review

References (111)

1. Abe K, Setoguchi Y, Hayashi T, Itoyama Y: In vivo adenovirus-mediated gene transfer and the expression in ischemic and reperfused rat brain. Brain Res 763:191-201, 1997.
2. Aebischer P, Schluep M, Deglon N, Joseph JM, Hirt L, Heyd B, Goddard, Hammang JP, Zurn AD, Kato AC, Regli F, Baetge EE: Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nature Med 2:696-699, 1996.
3. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M, Kahn A, Peschanski MR: Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 3:224-228, 1993.
4. Asahara T, Chen D, Tsurumi Y, Kearney M, Rossow S, Passeri J, Symes JF, Isner JM: Accelerated restitution of endothelial integrity and endothelium-dependent function after ph VEGF165 gene transfer. Circulation 94:3291-3302, 1996.
5. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A: Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet 3:229-234, 1993.
6. Berns KI, Giraud C: Adenovirus and adeno-associated virus as vectors for gene therapy. Ann N Y Acad Sci 772:95-104, 1995.
7. Betz AL, Yang GY, Davidson BL: Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab 15:547-551, 1995.
8. Blau HM, Springer ML: Gene therapy: A novel form of drug delivery. N Engl J Med 333:1204-1207, 1995.
9. Byrnes AP, MacLaren RE, Charlton HM: Immunological instability of persistent adenovirus vectors in the brain: Peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J Neurosci 16:3045-3055, 1996.
10. Caillaud C, Akli S, Vigne E, Koulakoff A, Perricaudet M, Poenaru L, Kahn A, Berwald-Netter Y: Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells. Eur J Neurosci 5:1287-1291, 1993.
11. Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM: Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267:518-522, 1995.
12. Chang MW, Barr E, Lu MM, Barton K, Leiden JM: Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 96:2260-2268, 1995.
13. Chang MW, Ohno T, Gordon D, Lu MM, Nabel GJ, Nabel EG, Leiden JM: Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery. Mol Med 1:172-181, 1995.
14. Chen LM, Chao L, Chao J: Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats. Hum Gene Ther 8:341-347, 1997.
15. Chen AF, O'Brien T, Tsutsui M, Kinoshita H, Pompili VJ, Crotty TB, Spector DJ, Katusic ZS: Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery. Circ Res 80:327-335, 1997.
16. Chen SJ, Wilson JM, Muller DW: Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation 89:1922-1928, 1994.
17. Chowdhury JR, Grossman M, Gupta S, Chowdhury NR, Baker JR Jr, Wilson JM: Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 254:1802-1805, 1991.
18. Clesham GJ, Browne H, Efstathiou S, Weissberg PL: Enhancer stimulation unmasks latent gene transfer after adenovirus-mediated gene delivery into human vascular smooth muscle cells. Circ Res 79:1188-1195, 1996.
19. Clowes MM, Lynch CM, Miller AD, Miller DG, Osborne WRA, Clowes AW: Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J Clin Invest 93:644-651, 1994.
20. Coffin RS, Howard MK, Cumming DV, Dollery CM, McEwan J, Yellon DM, Marber MS, MacLean AR, Brown SM, Latchman DS: Gene delivery to the heart in vivo and to cardiac myocytes and vascular smooth muscle cells in vitro using herpes virus vectors. Gene Ther 3:560-566, 1996.
21. Conte MS, Birinyi LK, Miyata T, Fallon JT, Gold HK, Whittemore AD, Mulligan RC: Efficient repopulation of denuded rabbit arteries with autologous genetically modified endothelial cells. Circulation 89:2161-2169, 1994.
22. Cotten M, Wagner E, Zatloukal K, Phillips S, Curiel DT, Birnstiel ML: High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc Natl Acad Sci U S A 89:6094-6098, 1992.
23. Crystal RG: Transfer of genes to humans: Early lessons and obstacles to success. Science 270:404-410, 1995.
24. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ: A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 3:219-223, 1993.
25. Doran SE, Ren XD, Betz AL, Pagel MA, Neuwelt EA, Roessler BJ, Davidson BL: Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Neurosurgery 36:965-970, 1995.
26. Draghia R, Caillaud C, Manicom R, Pavirani A, Kahn A, Poenaru L: Gene delivery into the central nervous system by nasal instillation in rats. Gene Ther 2:418-423, 1995.
27. French BA, Mazur W, Ali NM, Geske RS, Finnigan JP, Rodgers GP, Roberts R, Raizner AE: Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation 90:2402-2413, 1994.
28. Ghadge GD, Roos RP, Kang UJ, Wollmann R, Fishman PS, Kalynych AM, Barr E, Leiden JM: CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther 2:132-137, 1995.
29. Grossman M, Raper SE, Kozarsky KF, Stein E, Engelhardt JF, Muller D, Lupien PL, Wilson JM: Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet 6:335-341, 1994.
30. Guzman RJ, Hirschowitz EA, Brody SL, Crystal RG, Epstein SE, Finkel T: In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci U S A 91:10732-10736, 1994.
31. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T: Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation 88:2838-2848, 1993.
32. Hara S, Morishita R, Tone Y, Yokoyama C, Inoue H, Kaneda Y, Ogihara T, Tanabe T: Overexpression of prostacyclin synthase inhibits growth of vascular smooth muscle cells. Biochem Biophys Res Commun 216:862-867, 1995.
33. Heistad DD, Faraci FM: Gene therapy for cerebral vascular disease. Stroke 27:1688-1693, 1996.
34. Herbert F: Dune. New York, Putnam, 1965.
35. Hobbs FB, Damon BL (eds): 65+ in the United States. Washington, U.S. Government Printing Office, 1996, pp 3-23.
36. Huard J, Akkaraju G, Watkins SC, Pike-Cavalcoli M, Glorioso JC: LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus Type 1 mutant vector. Hum Gene Ther 8:439-452, 1997.
37. Huard J, Lochmuller H, Acsadi G, Jani A, Holland P, Guerin C, Massie B, Karpati G: Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. Exp Mol Pathol 62:131-143, 1995.
38. Ishibash H, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J: Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92:883-893, 1993.
39. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF: Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348:370-374, 1996.
40. Jiao S, Gurevich V, Wolff JA: Long-term correction of rat model of Parkinson's disease by gene therapy. Nature 362:450-453, 1993.
41. Kajiwara K, Byrnes AP, Charlton HM, Wood MJA, Wood KJ: Immune responses to adenoviral vectors during gene transfer in the brain. Hum Gene Ther 8:253-265, 1997.
42. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ: Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8:148-154, 1994.
43. Karpati G, Lochmuller H, Nalbantoglu J, Durham S: The principles of gene therapy for the nervous system. Trends Neurosci 19:49-54, 1996.
44. Kozarsky KF, McKinley DR, Austin LL, Raper SE, Stratford-Perricaudet LD, Wilson JM: In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable rabbit with recombinant adenoviruses. J Biol Chem 269:13695-13702, 1994.
45. Kramm CM, Rainov NG, Sena-Esteves M, Barnett FH, Chase M, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO: Longterm survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment. Hum Gene Ther 7:1989-1994, 1996.
46. Kreuzer J, Denger S, Reifers F, Beisel C, Haack K, Gebert J, Kubler W: Adenovirus-assisted lipofection: Efficient in vitro gene transfer of luciferase and cytosine deaminase to human smooth muscle cells. Atherosclerosis 124:49-60, 1996.
47. Kullo IJ, Schwartz RS, Pompili VJ, Tsutsui M, Milstien S, Fitzpatrick LA, Katusic ZS, O'Brien T: Expression and function of recombinant endothelial NO synthase in coronary artery smooth muscle cells. Arterioscler Thromb Vasc Biol 17:2405-2412, 1997.
48. Lafont A, Loirand G, Pacaud P, Vilde F, Lemarchand P, Escande D: Vasomotor dysfunction early after exposure of normal rabbit arteries to an adenoviral vector. Hum Gene Ther 8:1033-1040, 1997.
49. Lawrence MS, Ho DY, Sun GH, Steinberg GK, Sapolsky RM: Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci 16:486-496, 1996.
50. Lawrence MS, McLaughlin JR, Sun GH, Ho DY, McIntosh L, Kunis DM, Sapolsky RM, Steinberg GK: Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke. J Cereb Blood Flow Metab 17:740-744, 1997.
51. Lawrence MS, Sun GH, Kunis DM, Saydam TC, Dash R, Ho DY, Sapolsky RM, Steinberg GK: Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke. J Cereb Blood Flow Metab 16:181-185, 1996.
52. Leclerc G, Gal D, Takeshita S, Nikol S, Weir L, Isner JM: Percutaneous arterial gene transfer in a rabbit model: Efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest 90:936-944, 1992.
53. Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA: In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res 73:797-807, 1993.
54. Le Gal La Salle G, Roberts JJ, Berrard S, Ridoux V, Stratford-Perricaudet LD, Mallet J: An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988-990, 1993.
55. 1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci U S A 89:6482-6486, 1992.
56. Lemarchand P, Jones M, Yamada I, Crystal RG: In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res 72:1132-1138, 1993.
57. Lim CS, Chapman GD, Gammon RS, Muhlestein JB, Bauman RP, Stack RS, Swain JL: Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation 83:2007-2011, 1991.
58. Linnik MD, Zahos P, Geschwind MD, Federoff HJ: Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 26:1670-1675, 1995.
59. Lynch CM, Clowes MM, Osborne WR, Clowes AW, Miller AD: Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: A model for gene therapy. Proc Natl Acad Sci U S A 89:1138-1142, 1992.
60. Lynch CM, Hara PS, Leonard JC, Williams JK, Dean RH, Geary RL: Adeno-associated virus vectors for vascular gene delivery. Circ Res 80:497-505, 1997.
61. Macdonald RL, Stoodley M: Pathophysiology of cerebral ischemia. Neurol Med Chir 38:1-11, 1998.
62. Majesky MW: A little VEGF goes a long way: Therapeutic angiogenesis by direct injection of vascular endothelial growth factor-encoding plasmid DNA. Circulation 94:3062-3064, 1996.
63. Mann MJ, Gibbons GH, Kernoff RS, Diet FP, Tsao PS, Cooke JP, Kaneda Dzau VJ: Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci U S A 92:4502-4506, 1995.
64. Manno EM, Gress DR, Ogilvy CS, Stone CM, Zervas NT: The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher Grade 3 subarachnoid hemorrhages: A pilot study. Neurosurgery 40:289-293, 1997.
65. McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ: Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 713:99-107, 1996.
66. Melnick JL, Adam E, DeBakey ME: Cytomegalovirus and atherosclerosis. Eur Heart J 14[Suppl]:K30-K38, 1993.
67. Messina LM, Podrazik RM, Whitehill TA, Ekhterae D, Brothers TE, Wilson JM, Burkel WE, Stanley JC: Adhesion and incorporation of lacZ-transduced endothelial cells into the intact capillary wall in the rat. Proc Natl Acad Sci U S A 89:12018-12022, 1992.
68. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci U S A 90:8474-8478, 1993.
69. Muhonen MG, Ooboshi H, Welsh MJ, Davidson BL, Heistad DD: Gene transfer to cerebral blood vessels after subarachnoid hemorrhage. Stroke 28:822-828, 1997.
70. Nabel EG: Gene therapy for vascular diseases. Atherosclerosis 118 [Suppl]:S51-S56, 1995.
71. Nabel EG, Plautz G, Boyce FM, Stanley JC, Nabel GJ: Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 244:1342-1344, 1989.
72. Nabel EG, Plautz G, Nabel GJ: Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 249:1285-1288, 1990.
73. Newman KD, Dunn PF, Owens JW, Schulick AH, Virmani R, Sukhova G, Libby P, Dichek DA: Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 96:2955-2965, 1995.
74. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG: Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265:781-784, 1994.
75. Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF: Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 4:39-69, 1993.
76. Ono T, Fujino Y, Tsuchiya T, Tsuda M: Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells. Neurosci Lett 117:259-263, 1990.
77. Ooboshi H, Welsh MJ, Rios CD, Davidson BL, Heistad DD: Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ Res 77:7-13, 1995.
78. + T cell deficiency. Hum Gene Ther 7:1813-1826, 1996.
79. Phillips MI, Mohuczy-Dominiak D, Coffey M, Galli SM, Kimura B, Wu P, Zelles T: Prolonged reduction of high blood pressure with an in vivo nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense. Hypertension 29: 374-380, 1997.
80. Plautz G, Nabel EG, Nabel GJ: Introduction of vascular smooth muscle cells expressing recombinant genes in vivo. Circulation 83:578-583, 1991.
81. Rade JJ, Schulick AH, Virmani R, Dichek DA: Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nature Med 2:293-298, 1996.
82. Raja-Walia R, Webber J, Naftilan J, Chapman GD, Naftilan AJ: Enhancement of liposome-mediated gene transfer into vascular tissue by replication deficient adenovirus. Gene Ther 2:521-530, 1995.
83. Ram Z, Walbridge S, Oshiro EM, Viola JJ, Chiang Y, Mueller SN, Blaese RM, Oldfield EH: Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Res 54:2141-2145, 1994.
84. Rios CD, Ooboshi H, Piegors D, Davidson BL, Heistad DD: Adenovirus-mediated gene transfer to normal and atherosclerotic arteries: A novel approach. Arterioscler Thromb Vasc Biol 15:2241-2245, 1995.
85. Roessler BJ, Davidson BL: Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes. Neurosci Lett 167:5-10, 1994.
86. Rolling F, Nong Z, Pisvin S, Collen D: Adeno-associated virus-mediated gene transfer into rat carotid arteries. Gene Ther 4:757-761, 1997.
87. Rome JJ, Shayani V, Flugelman MY, Newman KD, Farb A, Virmani R, Dichek DA: Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall: Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler Thromb Vasc Biol 14: 148-161, 1994.
88. Rosenfeld MR, Bergman I, Schramm L, Griffin JA, Kaplitt MG, Meneses PI: Adeno-associated viral vector gene transfer into leptomeningeal xenografts. J Neurooncol 34:139-144, 1997.
89. Schulick AH, Newman KD, Virmani R, Dichek DA: In vivo gene transfer into injured carotid arteries: Optimization and evaluation of acute toxicity. Circulation 91:2407-2414, 1995.
90. Schwartz SM, deBlois D, O'Brien ERM: The intima: Soil for atherosclerosis and restenosis. Circ Res 77:445-465, 1995.
91. Simons M, Edelman ER, DeKeyser JL, Langer R, Rosenberg RD: Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359:67-70, 1992.
92. Song S, Wang Y, Bak SY, Lang P, Ullrey D, Neve RL, O'Malley KL, Geller AI: An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J Neurochem 68:1792-1803, 1997.
93. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE: Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394, 1994.
94. Steg PG, Feldman LJ, Scoazec JY, Tahlil O, Barry JJ, Boulechfar S, Ragot T, Isner JM, Perricaudet M: Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circulation 90:1648-1656, 1994.
95. Takahashi JC, Saiki M, Miyatake S, Tani S, Kubo H, Goto K, Aoki T, Takahashi JA, Nagata I, Kikuchi H: Adenovirus-mediated gene transfer of basic fibroblast growth factor induces in vitro angiogenesis. Atherosclerosis 132:199-205, 1997.
96. Takamiya Y, Short MP, Moolten FL, Fleet C, Mineta T, Breakefield XO, Martuza RL: An experimental model of retrovirus gene therapy for malignant brain rumors. J Neurosurg 79:104-110, 1993.
97. Takeshita S, Gal D, Leclerc G, Pickering JG, Riessen R, Weir L, Isner JM: Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation: In vitro and in vivo findings in a rabbit model of vascular injury. J Clin Invest 93:652-661, 1994.
98. Takeshita S, Tsurumi Y, Couffinahl T, Asahara T, Bauters C, Symes J, Ferrara N, Isner JM: Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 75:487-501, 1996.
99. Tripathy SK, Black HB, Goldwasser E, Leiden JM: Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2:545-550, 1996.
100. Tripathy SK, Goldwasser E, Lu MM, Barr E, Leiden JM: Stable delivery of physiological levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc Natl Acad Sci U S A 91:11557-11561, 1994.
101. Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passed J, Horowitz JR, Symes JF, Isner JM: Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94:3281-3290, 1996.
102. Vincent AJ, Esandi MD, van Someren G, Noteboom JL, Avezaat CJ, Vecht C, Smitt PA, van Bekkum DW, Valerio D, Hoogerbrugge PM, Bout A: Treatment of leptomeningeal metastases in a rat model using a recombinant adenovirus containing the HSV-tk genes. J Neurosurg 85:648-654, 1996.
103. von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ: Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 92:1137-1141, 1995.
104. Wagner E, Zatloukal K, Cotten M, Kirlappos H, Mechtler K, Curiel DT, Birnstiel ML: Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci U S A 89:6099-6103, 1992.
105. Willard JE, Landau C, Glamann DB, Burns D, Jessen ME, Pirwitz MJ, Gerard RD, Meidell RS: Genetic modification of the vessel wall: Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation 89:2190-2197, 1994.
106. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL: Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468, 1990.
107. Yang GY, Zhao YJ, Davidson BL, Betz AL: Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Res 751:181-188, 1997.
108. Yenari MA, Fink SL, Sun GH, Patel M, Kunis DM, Sapolsky RM, Steinberg GK: Gene transfer with defective herpes simplex virus vectors expressing hsp72 in a rat model of stroke. J Cereb Blood Flow Metab 17[Suppl 1]:S453, 1997 (abstr).
109. Zhou H, Zeng G, Zhou A, Tang J, Huang Q, Chen G, Peng T, Hu B: Adenovirus mediated gene transfer of vascular smooth muscle cells and endothelial cells in vitro. Chin Med J 108:493-496, 1995.
110. Zhu NL, Wu L, Liu PX, Gordon EM, Anderson WF, Starnes VA, Hall FL: Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation. Circulation 96: 628-635, 1997.
111. Zlokovic BV, Apuzzo MLJ: Cellular and molecular neurosurgery: Pathways from concept to reality - Part I: Target disorders and concept approaches to gene therapy of the central nervous system. Neurosurgery 40:789-803, 1997.